TY - JOUR
T1 - Objective and subjective neurocognitive functioning in functional motor symptoms and functional seizures: preliminary findings
AU - Pick, Susannah
AU - Millman, L S Merritt
AU - Sun, Yiqing
AU - Short, Eleanor
AU - Stanton, Biba R.
AU - Winston, Joel
AU - Mehta, Mitul
AU - Nicholson, Timothy
AU - Reinders, Antje A. T. S.
AU - David, Anthony
AU - Edwards, Mark
AU - Goldstein, Laura
AU - Hotopf, Matthew
AU - Chalder, Trudie
N1 - Publisher Copyright:
© 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
PY - 2023/9/19
Y1 - 2023/9/19
N2 - Introduction: This study aimed to provide a preliminary assessment of objective and subjective neurocognitive functioning in individuals with functional motor symptoms (FMS) and/or functional seizures (FS). We tested the hypotheses that the FMS/FS group would display poorer objective attentional and executive functioning, altered social cognition, and reduced metacognitive accuracy. Method: Individuals with FMS/FS (n = 16) and healthy controls (HCs, n = 17) completed an abbreviated CANTAB battery, and measures of intellectual functioning, subjective cognitive complaints, performance validity, and comorbid symptoms. Subjective performance ratings were obtained to assess local metacognitive accuracy. Results: The groups were comparable in age (p = 0.45), sex (p = 0.62), IQ (p = 0.57), and performance validity (p-values = 0.10–0.91). We observed no impairment on any CANTAB test in this FMS/FS sample compared to HCs, although the FMS/FS group displayed shorter reaction times on the Emotional Bias task (anger) (p = 0.01, np2 = 0.20). The groups did not differ in subjective performance ratings (p-values 0.15). Whilst CANTAB attentional set-shifting performance (total trials/errors) correlated with subjective performance ratings in HCs (p-values<0.005, r
s = −0.85), these correlations were non-significant in the FMS/FS sample (p-values = 0.10–0.13, r
s-values = −0.46–0.50). The FMS/FS group reported more daily cognitive complaints than HCs (p = 0.006, g = 0.92), which were associated with subjective performance ratings on CANTAB sustained attention (p = 0.001, r
s = −0.74) and working memory tests (p < 0.001, r
s = −0.75), and with depression (p = 0.003, r
s = 0.70), and somatoform (p = 0.003, r
s = 0.70) and psychological dissociation (p-values<0.005, r
s-values = 0.67–0.85). Conclusions: These results suggest a discordance between objective and subjective neurocognitive functioning in this FMS/FS sample, reflecting intact test performance alongside poorer subjective cognitive functioning. Further investigation of neurocognitive functioning in FND subgroups is necessary.
AB - Introduction: This study aimed to provide a preliminary assessment of objective and subjective neurocognitive functioning in individuals with functional motor symptoms (FMS) and/or functional seizures (FS). We tested the hypotheses that the FMS/FS group would display poorer objective attentional and executive functioning, altered social cognition, and reduced metacognitive accuracy. Method: Individuals with FMS/FS (n = 16) and healthy controls (HCs, n = 17) completed an abbreviated CANTAB battery, and measures of intellectual functioning, subjective cognitive complaints, performance validity, and comorbid symptoms. Subjective performance ratings were obtained to assess local metacognitive accuracy. Results: The groups were comparable in age (p = 0.45), sex (p = 0.62), IQ (p = 0.57), and performance validity (p-values = 0.10–0.91). We observed no impairment on any CANTAB test in this FMS/FS sample compared to HCs, although the FMS/FS group displayed shorter reaction times on the Emotional Bias task (anger) (p = 0.01, np2 = 0.20). The groups did not differ in subjective performance ratings (p-values 0.15). Whilst CANTAB attentional set-shifting performance (total trials/errors) correlated with subjective performance ratings in HCs (p-values<0.005, r
s = −0.85), these correlations were non-significant in the FMS/FS sample (p-values = 0.10–0.13, r
s-values = −0.46–0.50). The FMS/FS group reported more daily cognitive complaints than HCs (p = 0.006, g = 0.92), which were associated with subjective performance ratings on CANTAB sustained attention (p = 0.001, r
s = −0.74) and working memory tests (p < 0.001, r
s = −0.75), and with depression (p = 0.003, r
s = 0.70), and somatoform (p = 0.003, r
s = 0.70) and psychological dissociation (p-values<0.005, r
s-values = 0.67–0.85). Conclusions: These results suggest a discordance between objective and subjective neurocognitive functioning in this FMS/FS sample, reflecting intact test performance alongside poorer subjective cognitive functioning. Further investigation of neurocognitive functioning in FND subgroups is necessary.
KW - cognitive
KW - neuropsychological
KW - attention
KW - memory
KW - executive function
KW - social cognition
KW - functional neurological disorder
KW - functional seizures
KW - Psychogenic non-epileptic seizures
KW - dissociative (nonepileptic) seizures
KW - Functional movement disorder
KW - functional motor disorder
KW - conversion disorder
KW - metacognition
UR - http://www.scopus.com/inward/record.url?scp=85171691531&partnerID=8YFLogxK
U2 - 10.1080/13803395.2023.2245110
DO - 10.1080/13803395.2023.2245110
M3 - Article
SN - 0168-8634
JO - Journal of Clinical and Experimental Neuropsychology
JF - Journal of Clinical and Experimental Neuropsychology
ER -